Celsense offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The mission of the company is to be the standard for cellular imaging in human health.
Celsense is a privately held biotechnology company offering novel MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company’s products have application in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with leading pharmaceutical and biotechnology organizations and is developing products suitable for human use.
Celsense was founded in 2005 to commercialize imaging platforms developed at Carnegie Mellon University.

Celsense Leadership
BOARD OF DIRECTORS
- Gregory T. Hebrank, M.D.
- Charles F. O’Hanlon, President and CEO
- Thomas Petzinger, Jr.
- L. Gerald Tarantino, J.D.
Latest News

The First Patient Treated in New Clinical Trial Using Cell Sense
The First Patient Treated in New Clinical Trial Using Cell Sense
read more
Celsense, Inc. to Give Company Presentation at the Cell and Gene Meeting on the Mesa
Celsense, Inc. to Give Company Presentation at the Cell and Gene Meeting on the Mesa
read more
US National Institutes of Health Awards Phase II SBIR Grant to Celsense for Immunotherapy Clinical Trial Using Novel MRI Agent
US National Institutes of Health Awards Phase II SBIR Grant to Celsense for Immunotherapy Clinical Trial Using Novel MRI Agent
read moreContinue Exploring
Products
Papers
Real-Time Results,<br />Faster and More Accurate
Celsense offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The mission of the company is to be the standard for cellular imaging in human health.
GET IN TOUCH
Send Us A Message
© 2020 Celsense, Inc. All rights reserved.